CXCR4 and prostate carcinoma: In addition, using a prostate cancer model, CXCR4-dependent migration was shown to increase matrix metalloproteinase-9 (MMP-9) expression and decrease TIMP metallopeptidase inhibitor 2 (TIMP2) expression, contributing to a more invasive phenotype [44,45].